Press Releases September 4, 2026 06:32 PM

Schedule update: Stryker to participate in the 2026 Wells Fargo Healthcare Conference

Stryker Corporation announces participation in the 2026 Wells Fargo Healthcare Conference with key executives presenting.

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
SYK

Stryker Corporation, a global leader in medical technologies, confirmed their participation in the 2026 Wells Fargo Healthcare Conference on September 8, 2026. Executive leadership will engage in a fireside chat session and provide insights via a live webcast. The company continues to focus on innovation in medical devices impacting MedSurg, Neurotechnology, and Orthopaedics sectors.

Schedule update: Stryker to participate in the 2026 Wells Fargo Healthcare Conference
SYK
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Stryker will present at the 2026 Wells Fargo Healthcare Conference on September 8, 2026.
  • Senior executives, including CFO Preston Wells and VP Investor Relations Nick Mead, will participate in a fireside chat session.
  • Stryker is a recognized leader in medical technologies impacting patient care across multiple sectors: MedSurg, Neurotechnology, and Orthopaedics.

Portage, Michigan, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2026 Wells Fargo Healthcare Conference on Tuesday, September 8, 2026, at the Encore Boston Harbor, as previously reported.

Preston Wells, Vice President, Chief Financial Officer and Nick Mead, Vice President, Investor Relations will now participate in a fireside chat session at 10:15 a.m. (Eastern time). A simultaneous live audio webcast and replay of the session can be accessed at Stryker - Events & Presentations.

About Stryker

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.

Contacts

For investor inquiries:
Nick Mead, Vice President, Investor Relations at 269-385-2600 or nick.mead@stryker.com   

For media inquiries:

Kim Montagnino, Vice President, Chief Communications Officer at 269-385-2600 or kim.montagnino@stryker.com


Risks

  • The announcement is routine and does not include new financial or product data that might immediately influence investor expectations.
  • Market reaction may depend on additional disclosure or performance details during the conference, which are currently unspecified.
  • Broader healthcare market conditions and regulatory risks continue to affect medical technology companies including Stryker.

More from Press Releases

Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen Sep 4, 2026 Grupo Aeroportuario del Pacifico Reports a Passenger Traffic Increase in August 2026 of 0.5% Compared to 2025 Sep 4, 2026 Alpha Compute Corp. Market Update Sep 4, 2026 HII Details Strategy to Increase Shipbuilding Pace for U.S. Navy Sep 4, 2026 Phaos Technology Holdings (Cayman) Limited Announces Results of Extraordinary General Meeting Sep 4, 2026